1. Home
  2. TGTX vs PAYP Comparison

TGTX vs PAYP Comparison

Compare TGTX & PAYP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

N/A

Current Price

$64.36

Market Cap

8.5B

Sector

Health Care

ML Signal

N/A

Logo PayPay Corporation American Depository Shares

PAYP

PayPay Corporation American Depository Shares

N/A

Current Price

$12.99

Market Cap

10.2B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
TGTX
PAYP
Founded
1993
2018
Country
United States
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
10.2B
IPO Year
2008
2025

Fundamental Metrics

Financial Performance
Metric
TGTX
PAYP
Price
$64.36
$12.99
Analyst Decision
Buy
Strong Buy
Analyst Count
8
13
Target Price
★ $69.43
$23.41
AVG Volume (30 Days)
★ 1.8M
467.9K
Earning Date
11-09-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1746.67
N/A
EPS
★ 0.52
N/A
Revenue
★ $2,785,000.00
N/A
Revenue This Year
$61.95
$26.54
Revenue Next Year
$35.55
$17.55
P/E Ratio
$120.60
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$26.76
$12.07
52 Week High
$68.03
$24.89

Technical Indicators

Market Signals
Indicator
TGTX
PAYP
Relative Strength Index (RSI) 60.53 35.59
Support Level $52.12 $12.07
Resistance Level $63.60 $16.40
Average True Range (ATR) 3.52 0.70
MACD 0.14 -0.17
Stochastic Oscillator 64.62 3.28

Price Performance

Historical Comparison
TGTX
PAYP

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

About PAYP PayPay Corporation American Depository Shares

PayPay is a financial technology company jointly owned by Softbank and LY. It was founded in 2018, following the success of Alipay and WeChat Pay in China, and was the pioneering code payment app in Japan. Over the past seven years, it has amassed more than 70 million users and is the market leader in code payments.

Share on Social Networks: